- Home
- CLW vs AMLX Comparison
CLW vs AMLX Comparison
Compare CLW & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLW
- AMLX
- Stock Information
- Founded
- CLW 2005
- AMLX 2014
- Country
- CLW United States
- AMLX United States
- Employees
- CLW N/A
- AMLX N/A
- Industry
- CLW Paper
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- CLW Basic Materials
- AMLX Health Care
- Exchange
- CLW Nasdaq
- AMLX Nasdaq
- Market Cap
- CLW 501.0M
- AMLX 481.9M
- IPO Year
- CLW N/A
- AMLX 2022
- Fundamental
- Price
- CLW $31.02
- AMLX $3.45
- Analyst Decision
- CLW Buy
- AMLX Buy
- Analyst Count
- CLW 1
- AMLX 7
- Target Price
- CLW $37.00
- AMLX $7.60
- AVG Volume (30 Days)
- CLW 534.1K
- AMLX 921.2K
- Earning Date
- CLW 02-18-2025
- AMLX 02-20-2025
- Dividend Yield
- CLW N/A
- AMLX N/A
- EPS Growth
- CLW N/A
- AMLX N/A
- EPS
- CLW 0.88
- AMLX N/A
- Revenue
- CLW $2,211,900,000.00
- AMLX $196,485,000.00
- Revenue This Year
- CLW N/A
- AMLX N/A
- Revenue Next Year
- CLW N/A
- AMLX N/A
- P/E Ratio
- CLW $257.11
- AMLX N/A
- Revenue Growth
- CLW 58.65
- AMLX N/A
- 52 Week Low
- CLW $23.97
- AMLX $1.58
- 52 Week High
- CLW $57.13
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- CLW 62.69
- AMLX 38.58
- Support Level
- CLW $28.11
- AMLX $3.02
- Resistance Level
- CLW $30.71
- AMLX $3.67
- Average True Range (ATR)
- CLW 1.22
- AMLX 0.26
- MACD
- CLW 0.06
- AMLX 0.01
- Stochastic Oscillator
- CLW 89.80
- AMLX 37.07
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.